Moncef Slaoui, who led Trump's Operation Warp Speed, was dismissed as chair of Galvani Bioelectronics' board of directors after an investigation.
David Sinclair stirred up controversy before when he promoted — and got $8 million — off a “miraculous molecule.”
It's 23andMe's latest collaboration to develop new drugs with genetic data from customers who volunteered to participate.
Sales of Biktarvy are expected to be about $1 billion this year.
Gottlieb's financial ties to the healthcare industry are extensive.
The Beyond Zero campaign has been instrumental in raising the consciousness of the entire nation regarding the plight of
Franklin Graham took to Facebook to announce he is moving his accounts to another bank to protest the Wells Fargo commercial featuring a lesbian couple. He is boycotting Tiffany's because they are selling wedding rings to gay couples. So is it safe to assume that he will be moving his Facebook and Twitter and Google and YouTube accounts to other media? Friendster, maybe?
The vaccine, co-developed by the National Institutes of Health in the United States and Okairos, a biotechnology firm acquired
With the world increasingly and economically beholden to China and Chinese business, China's globalization strategy has won dividends at home and abroad.
Bioelectronic medicine (BEM) is the most recent medical revolution -- not an innovation or an improvement or a step up but a radical reimagining of our understanding that it should be possible to treat human illnesses using electrical signals to replace some drugs.
The pharmaceutical sector is still struggling to find an operating model that will work in the 21st century. The shocking news of GlaxoSmithKline's sale of its cancer-drug business to Novartis -- and the many recent huge deals like it -- are the most recent evidence.
By Ben Hirschler "Given the problems Glaxo had in China, it is important for investors to understand, at a deeper level, just
My vision is for a World AIDS Day in the near future where we can say with pride that we have achieved universal access to treatment. This goal is within reach, but only by supporting important initiatives to make medicines available, appropriate, and affordable will we fully be able to grasp it.
Twelve civil rights groups are joining GSK in its argument, the San Jose Mercury News reported. A legal battle between two
It's sketchy business, bribing foreign officials -- sketchy enough that it's hard to believe some of America's most well
At a recent summit of manufacturing leaders in Raleigh, John Bolla of GlaxoSmithKline, noted, "if you aren't partnering with
The best way for companies to design and implement global pro bono programs that maximize the benefits of their ICV programs is through partnerships and collaboration.
Pharmaceutical giant Glaxo made profits in ways that manipulated the choices of doctors and sometimes resulted in patients' being subjected to significant risks without their informed consent.
The health professions would do far more good stopping the drugging of children than continuing or increasing it. Ethical professionals need to work toward removing children from psychiatric drugs.